tiprankstipranks
Advertisement
Advertisement

ABOS Stock Latest News

Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
Company AnnouncementsAcumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
5d ago
ABOS
Acumen files to sell 10.83M shares of common stock for holders
PremiumThe Fly
Acumen files to sell 10.83M shares of common stock for holders
14d ago
ABOS
Options Volatility and Implied Earnings Moves Today, March 26, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 26, 2026
14d ago
CMC
ABOS
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
PremiumCompany Announcements
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
14d ago
8K
ABOS
Is ABOS a Buy, Before Earnings?
PremiumPre-Earnings
Is ABOS a Buy, Before Earnings?
16d ago
ABOS
Acumen participates in a conference call with Cantor
PremiumThe FlyAcumen participates in a conference call with Cantor
17d ago
ABOS
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
Premium
The Fly
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
23d ago
ABOS
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
Premium
Ratings
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
23d ago
ABOS
Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
PremiumRatings
Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
23d ago
ABOS
Acumen price target raised to $8 from $7 at BTIG
PremiumThe Fly
Acumen price target raised to $8 from $7 at BTIG
23d ago
ABOS
Acumen Raises Capital to Advance Enhanced Brain Delivery
PremiumCompany Announcements
Acumen Raises Capital to Advance Enhanced Brain Delivery
24d ago
8K
ABOS
Acumen announces $35.75M private placement
PremiumThe Fly
Acumen announces $35.75M private placement
24d ago
ABOS
Acumen price target raised to $7 from $4 at BTIG
PremiumThe FlyAcumen price target raised to $7 from $4 at BTIG
2M ago
ABOS
BIIB
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
Premium
Stock Analysis & Ideas
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
3M ago
ABOS
SABS
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
Premium
Company Announcements
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
3M ago
8K
ABOS
Acumen initiated with a Buy at Lucid Capital
PremiumThe Fly
Acumen initiated with a Buy at Lucid Capital
4M ago
ABOS
Acumen announces new research at CTAD on ACU193
PremiumThe Fly
Acumen announces new research at CTAD on ACU193
4M ago
ABOS
Acumen price target lowered to $8 from $9 at BofA
PremiumThe Fly
Acumen price target lowered to $8 from $9 at BofA
5M ago
ABOS
Acumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
PremiumThe Fly
Acumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
5M ago
ABOS
Acumen Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAcumen Pharmaceuticals Reports Q3 2025 Financial Results
5M ago
ABOS
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
Premium
Company Announcements
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
5M ago
ABOS
Acumen Pharmaceuticals Reports Q3 Financial Results
Premium
Company Announcements
Acumen Pharmaceuticals Reports Q3 Financial Results
5M ago
8K
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >